Radisens extends European Space Agency partnership with €1.6m contract

 In News

Radisens extends European Space Agency (ESA) partnership with €1.6M contract…

Cork, Ireland – Oct 27th, 2016 – Radisens Diagnostics, a Cork based medical diagnostics company which specialises in developing near-patient devices that instantly test and monitor for high-burden chronic diseases, today announced a contract worth €1.6 million with the European Space Agency (ESA). The partnership is supported by the Department of Jobs, Enterprise and Innovation through Enterprise Ireland and is the third contract agreed between Radisens and ESA in recent years. .

The new contract will see the company integrate multiple technologies required for human spaceflight onto its novel Gemini™ platform, a multi-mode device which allows for decentralised diagnostics. The resulting device will be used aboard the International Space Station and on various human spaceflight missions in the future. The technologies to be developed under the ESA programme will also have potential applications for use on earth to monitor the health of patients diagnosed with chronic diseases such as diabetes and heart disease, by testing a fraction of a blood droplet through a single device.

Radisens’ CEO, Jerry O’Brien, expressed his delight with the deal saying that “we are very pleased to extend our long-term partnership with ESA, to develop real-time blood testing technologies for use in space. There are many parallels between blood testing requirements for both space and clinical use such as ease-of-use, compact devices, fast turnaround time and removing the use of needles. Our solutions for the tougher space requirements will benefit both patients and clinicians to better manage chronic disease as we integrate them into our commercial product.”

ESA’s Technical Officer, Francois Gaubert, welcomed this partnership extension saying “Moving forward in the development of such a technology with Radisens is a very exciting goal and experience. Blood analysis on astronauts has always been dependent on the return to earth of the samples. Hopefully in the near future, physiological parameters of Astronauts onboard the ISS could be monitored within minutes. This would be a major step towards the use of Point of Care diagnostics during future manned exploration missions e.g. a long duration mission to a lunar outpost. The needs of potential space applications will be served by the miniaturization, robustness, and the easy-to-use qualities of the commercial device.”

In congratulating the company, Minister of State for Training, Skills and Innovation, Mr. John Halligan TD said “I wish to congratulate Radisens Diagnostics on winning another valuable contract with the European Space Agency. It clearly demonstrates the capacity of Irish companies to develop highly innovative technologies to meet the highly demanding requirements for space.   Radisens Diagnostics is one of a growing number of Irish companies benefitting from the Irish Governments investment in ESA to build new products, new markets and support high value job creation in Ireland.”

Tony McDonald, Programme Manager Enterprise Ireland added “Radisens is one of a growing number of companies developing highly innovative technologies for the commercial market with support from the European Space Agency. We expect to see the number of Irish companies engaging with ESA to grow steadily over the next three years.”


Notes to the Editor:

About Radisens Diagnostics

Radisens’ mission is to help shape decisions in healthcare by developing a point of care monitoring platform for integrated care management; testing at the right place, at the right time to enable better informed clinical interventions.

Radisens’ focus is to improve the management of high cost chronic diseases. Our early focus is on diabetes and cardiovascular disease, and their associated complexities and complications.

Our vision is to empower both those living with these conditions and their healthcare providers to reduce the challenges and costs of managing these conditions.

Radisens Diagnostics Limited is an established in vitro diagnostics company and was incorporated in 2009 based in Cork, Ireland

The European Space Agency

The European Space Agency (ESA) is Europe’s gateway to space. ESA is an intergovernmental organisation, created in 1975, with the mission to shape the development of Europe’s space capability and ensure that investment in space delivers benefits to the citizens of Europe and the world. ESA develops the launchers, spacecraft and ground facilities needed to keep Europe at the forefront of global space activities. Today it launches satellites for Earth observation, navigation, telecommunications and astronomy, sends probes to the far reaches of the Solar System and cooperates in the human exploration of space. www.esa.int

ESA plays a critical role in developing a strong European Space programme and space industry and has been fundamental to in developing the specialised, highly innovative, industrial capabilities that exist in the Irish space sector. ESA :-

  • Provides a significant capital investment support for in-company & 3rd level RDI in leading edge space technologies for commercial exploitation in the global space and non-space markets for the SME and MNC sector.
  • Supports the Enterprise Ireland and IDA Ireland strategy of supporting high potential start-ups, company scaling, as well as foreign direct investment.
  • Provides prioritised support for technology innovation and technology transfer that leads to exports, sales and employment generation by Irish industry.
  • A platform to fully exploit the opportunities of the Global space market and maximise the financial return and economic impacts of Ireland’s significant financial contributions to the EU space programme budgets.

More details on Enterprise Ireland, managing Ireland’s investment in the European Space Agency

Enterprise Ireland co-ordinates Ireland’s industrial and research participation in the programmes of the European Space Agency (ESA) in collaboration with the Department of Jobs, Enterprise and Innovation.

The purpose of Ireland’s membership of ESA is to participate in European space programmes with a focus on facilitating innovative Irish companies to develop leading edge space technologies and to commercially exploit their ESA participation in global space and non-space markets, leading to increased export sales and employment.

Enterprise Ireland’s role in relation to ESA is to assist Irish companies to successfully bid for ESA contracts, providing expertise for Irish companies and researchers in developing and executing space strategies, as well as being a point of reference for the international space industry when they want to identify relevant sources of space-related expertise within Ireland.

Irish industrial and research participation in ESA covers a range of sectors and technology areas including; software, precision mechanical engineering, telecommunications, electronics, optoelectronics and advanced materials and extending to end user equipment, services and applications.

Recent Posts

Leave a Comment